COVID-19 (Coronavirus Disease 2019) is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on December 2019, there was no information about this virus. Case Definition (India), Symptoms, Statistics, Preventive Measures, Management
Rekha Dehariya (M.Sc nursing 1st year) Bhopal Nursing College, Bhopal
Covid -19 has effected broud number of people all over the world. the health education is necessary to aware people about it.
COVID-19 (Coronavirus Disease 2019) is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on December 2019, there was no information about this virus. Case Definition (India), Symptoms, Statistics, Preventive Measures, Management
Rekha Dehariya (M.Sc nursing 1st year) Bhopal Nursing College, Bhopal
Covid -19 has effected broud number of people all over the world. the health education is necessary to aware people about it.
Covid 19 information for dialysis professionals and dialysis providers habeebHABEEB RAHMAN PK
Covid 19 information for dialysis professionals and dialysis providers . I know we are in the front of war against COVID-19 . This guide targeted to dialysis dialysis professionals like dialysis nurses ,dialysis technologist,dialysis technicians , social worker and admin team. Please find attachment
In COVID-19 any antiviral is more effective when used early in first week of illness.
What should not be used in covid-19 is also discussed in presentation.
Describes all about SARS CoV- 2 its introduction, epidemiology, life cycle of virus, its transmission, pathophysiology of the disease, its complications, diagnostic methods and management through different system of medicines.
This was a lecture I gave for the Upstate Nurse Practitioners Association. This is a comprehensive overview. I would to thank all health care professionals for doing their jobs as well as they can.
Covid 19 information for dialysis professionals and dialysis providers habeebHABEEB RAHMAN PK
Covid 19 information for dialysis professionals and dialysis providers . I know we are in the front of war against COVID-19 . This guide targeted to dialysis dialysis professionals like dialysis nurses ,dialysis technologist,dialysis technicians , social worker and admin team. Please find attachment
In COVID-19 any antiviral is more effective when used early in first week of illness.
What should not be used in covid-19 is also discussed in presentation.
Describes all about SARS CoV- 2 its introduction, epidemiology, life cycle of virus, its transmission, pathophysiology of the disease, its complications, diagnostic methods and management through different system of medicines.
This was a lecture I gave for the Upstate Nurse Practitioners Association. This is a comprehensive overview. I would to thank all health care professionals for doing their jobs as well as they can.
This presentation discusses COVID-19. It covers etiology, epidemiology, pathophysiology, clinical features, diagnosis, clinical management and treatment of COVID-19. It also discusses the effects of COVID-19 on pregnancy,how it manifests and how it is diagnosed and how it is managed. Hope this will help you.
A cardiologists perspective to current scenario in light of corona pandemic in india and world wide. cardiac procedures , heart disease , aceinhibitors , arni , heart failure , troponin, nt probnp
COVID-19 I Coronavirus Disease I Harshit JadavHarshit Jadav
This presentation highlights all the basic information regarding the current pandemic COVID-19.
This presentation includes an introduction, recent stats, the structure of coronavirus, pathogenesis of coronavirus, diagnosis, treatment and preventive measures of COVID-19
The recent pandemic has set the criteria of prevention in dentistry to a new bar.To combat covid 19 hopefully this is helpful to all my fellow dentists.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. COVID – 19 : PRIORITIES FOR PEDIATRIC
PRACTICE
MRS.Arati Mishra Ingalageri
M.Sc. Nursing (Pediatrics)
VICE PRINCIPAL
SET INSTITUTE OF NURSING- Junagadh
8/24/2020 Arati Mishra Ingalageri 2
3. INTRODUCTION
• Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease
caused by a newly discovered coronavirus (SARS-CoV-2).
• Previously SARS(Severe Acute Respiratory Syndrome-2002-2004), MERS
(Middle East Respiratory Syndrome-2012-2014) Epidemic was happened by Same
virus Family.
• COVID-19 is a zoonotic, enveloped, single-stranded ribonucleic acid (RNA) virus
that can quickly mutate and recombine, creating novel virus strains that spread
from animals to human and resulted in Pandemic situation as human don’t have
immunity for this virus.
• Coronaviruses are known for causing severe respiratory distress and respiratory
failure along with coagulopathies, multi-system organ failure, and death.
8/24/2020 Arati Mishra Ingalageri 3
4. STATISTICS AND DATA
• Children and Adolescents currently account for about 8% of confirmed
COVID 19 Cases in the world, which shows a smaller percentage of total
COVID-19 cases occurring in children
• Up to 13th August 2020,As per Centers for Disease Control and Prevention
7.6 % of 37,04,108 confirmed cases reported in children < 18 years.
1.6% of cases were in children aged 0-4 years
6% of cases were in children aged 5-17 years
• 40% increase in cases of COVID-19 is reported in children in July 2020.
8/24/2020 Arati Mishra Ingalageri 4
6. RISK FACTORS
• Exposure to household members with confirmed COVID 19
• Immuno compromising conditions such as ongoing treatment for cancer
• Congenital heart defects
• Chronic lung disease
• Moderate-to-severe asthma
• Severe obesity
• Diabetes
• Chronic kidney and liver disease
• Infants < 1 year old may be at increased
risk of severe or critical disease compared
to older children.8/24/2020 Arati Mishra Ingalageri 6
8. TRANSMISSION
• Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is transmitted
person-to-person.
• Primarily through close contact (within 6 feet) via respiratory droplets
produced when an infected person coughs or sneezes.
• Children carry the COVID-19 virus in the upper respiratory tract, making it
easier to spread in childcare centers, schools, and homes; where pediatric
respiratory hygiene is inconsistent and problematic.
8/24/2020 Arati Mishra Ingalageri 8
9. Continue….
• Contact with fomites may be possible, but it is not thought to be the primary
route of transmission
• Viability of SARS-CoV-2 suggests aerosol and fomite transmission,
6.8 hours on plastic
5.6 hours on stainless steel
3.5 hours on cardboard
1.1 hours in aerosol
0.8 hours in copper
• SARS-CoV-2 may be spread by people who are not showing symptoms
8/24/2020 Arati Mishra Ingalageri 9
11. CLINICAL MANIFESTATION
• It appears children present with similar symptoms described in adults
with active COVID-19 infection although most are either asymptomatic
or mildly symptomatic.
• Among all COVID 19 Confirmed Cases,
80% mild
14% Severe
5% critical and
Fatality is 1-3%.
• Incubation Period of COVID 19 Virus is 2-14days.
8/24/2020 Arati Mishra Ingalageri 11
12. • COVID-19 symptoms including,
• Fever
• Cough
• Shortness of Breath or difficulty in Breathing
• Chills, shivering
• Muscle aches
• Headache
• Sore throat
• Loss of taste and/or smell
• Congestion or running nose
• Nausea or Vomiting
• Diarrhea
• Poor Appetite
8/24/2020 Arati Mishra Ingalageri 12
13. Continue…
• Multisystem Inflammatory Syndrome in Children (MIS-C) is a new syndrome
being reported in small number of children during the COVID-19 pandemic
syndrome.
• It has features similar to other pediatric inflammatory conditions including
Kawasaki syndrome.(Bulbar non purulent conjunctivitis, cervical
lymphadenopathy, Strawberry tongue, Skin desquamation, Coronary artery
dilatation)
8/24/2020 Arati Mishra Ingalageri 13
15. INVESTIGATIONS
Supportive Investigation
Serological Investigation Includes,
• WBC normal or decreased
• Decreased neutrophils
• Thrombocytopenia
• CRP and procalcitonin Normal
• In Severe Cases:
Elevated liver Enzymes,
Abnormal coagulation Studies
Elevated D-dimer
8/24/2020 Arati Mishra Ingalageri 15
16. Continue…..
Radiological Investigation Includes,
• Bi-lateral, multiple patchy nodular
ground-glass opacities
• Infiltrating shadows in the middle/outer
zone of the lung or under the pleura
• Findings are often non-specific
Children have milder presentations than
adults Chest abnormalities may persist
for several months.
8/24/2020 Arati Mishra Ingalageri 16
17. Confirmatory Investigation
• Diagnosis confirmed with detection of SARS-CoV-2
RNA by reverse transcription polymerase chain
reaction (RT-PCR) in nasopharynx, oropharynx, or
nasal swab samples.
• Various commercially available kits are approved by
ICMR for use in India.
8/24/2020 Arati Mishra Ingalageri 17
18. TREATMENT
• It mainly consists of supportive care with provision of sufficient fluid and
calorie intake along with oxygen supplementation and airway support.
• Use of Remdesivir (Antiviral) for treatment of suspected or confirmed
COVID-19 in children.
• Use of Favipirivir For Treatment of moderate to sever cases.
• Use of Tociluzumab (IL6 Antagonist) for Treatment of sever cases.
• Supportive care may help to relieve symptoms and should include support of
vital organ functions in severe cases
• Vitamin D,Vitamin C, and Zinc Supplementation may play a role in reducing
the risk of COVID-19 infections.
8/24/2020 Arati Mishra Ingalageri 18
19. INDICATIONS FOR HOSPITAL
ADMISSION
• At present, the official guidelines recommend admission for
all confirmed cases. Particularly, patients classified as
“Severe Pneumonia” and “Critically ill” should be admitted to
hospital for further care. The following criteria may
particularly be considered for admission:
1. Respiratory distress
2. SpO2 < 92% on room air
3. Shock/ poor peripheral perfusion
4. Poor oral intake, especially in infants and young children
5. Lethargic, especially in infants and young children
6. Seizures/ encephalopathy8/24/2020 Arati Mishra Ingalageri 19
20. GENERAL MEASURES FOR
HOSPITALISED CHILD
• Oxygen supplementation to maintain SpO2 > 92%.
• Fluid management to prevent dehydration and overhydration.
• Symptomatic treatment (Paracetamol for fever).
• Avoid ibuprofen and other NSAIDs.
• Use of antimicrobials (e.g., Ceftriaxone) in case of suspected sepsis and septic
shock and use of antiviral (Oseltamivir) if influenza is suspected.
• Systemic corticosteroids if needed.
• Avoid Nebulization to prevent risk of aerosolization
• Use of inhaler and spacer is preferred for administration of inhaled medication.
• Close monitoring for Danger signs.
• Care of child with Ventilator.8/24/2020 Arati Mishra Ingalageri 20
21. MANAGEMENT
Children with cough/cold/fever of less
than 10 day duration
• No respiratory
Difficulty
• Feeding well
• SpO2 >92%
• Respiratory difficulty,
• SpO2 <92%,
• Not feeding well or
• Lethargic,
• Seizures
• Hospitalization if not
feasible- Home treatment
• Parental Education about
isolation
• Report to health care
facility if worsening of
Symptoms
• Home treatment
• No investigation
• Parental Education
about isolation and
• Report to health care
facility if worsening of
symptoms
Contact
No Contact
Continue…8/24/2020 Arati Mishra Ingalageri 21
22. • Initiate appropriate management
• Admit in designated ward till COVID report is available
Ward/ ICU:
COVID Sampling
Bedside Chest X-ray,
Lab tests
COVID test
POSITIVE
COVID test
NEGATIVE
Transfer to Designated area-ward/ ICU.• Transfer to ward/PICU and
• Manage as bronchiolitis/ CAP
8/24/2020 Arati Mishra Ingalageri 22
23. Children with COVID 19 RT-PCR Positive
Mild illness
• sore throat
• Rhinorrhea
• Cough
• No fast Breathing
Pneumonia
• Fast breathing
• No signs of sever
pneumonia
Severe pneumonia
• Cyanosis(SpO2 < 90%)
• Increased respiratory
Efforts (Grunting, severe
retraction)
• Lethargy somnolence,
• seizure
Critically ill
• Hospitalization if not feasible
Home isolation
• Supportive care
• Rest
• Adequate Hydration and
feeding
• PCM 10-15mg/kg for fever
• Explain Danger Signs.
• Hospitalization if not feasible Home
isolation
• Monitor for progress
• Feeds / fluids: avoid dehydration
and overhydration
• Paracetamol
• oral antibiotics(amoxiclav)
• Explain Danger Signs.8/24/2020 Arati Mishra Ingalageri 23
24. Severe
pneumonia
Critically ill
• Hospitalization in Isolation
• Hydroxy chloroquine Or Lopinavir/ritonavir
• Oxygen therapy: nasal prong, face mask
• Avoid nebulization
• Use Inhaler and spacer.
• Avoid HFNC(High Flow Nasal Cannula)
and NIV(Non Invasive Ventilation ) for
Prevention of aerosolization.
• Hospitalization in Isolation
Preferably Negative Pressure
room
• Hydroxy chloroquine Or
Lopinavir/ritonavir
• Monitor for secondary Bacterial
Infection Consider Antibiotics
• Organ support – renal
replacement.(if needed)
Septic Shock/Myocarditis
• Crystalloid bolus 10-20
ml/kg over 30-60 min, fast
if hypotensive
• Early inotrope support
• (Dopamine,Dobutamine)
• Monitor for fluid overload
ARDS
• Mechanical
ventilation:
• Low tidal volume
(6 ml/kg)
• High PEEP
• Cuffed ET tube
• Fluid Restriction
• Try prone Ventilation
• HFOV may be
considered
• ECMO if above fail8/24/2020 Arati Mishra Ingalageri 24
25. DISCHARGE CRITERIA
• For mild cases Patient can be discharged after 10 days of
symptom onset and no fever for 3 days and advised to isolate
at home for further 7 days for mild cases.
• For moderate cases admitted to dedicated COVID health
centers, if fever resolve with in 3 days and maintain saturation
above 95% for next 4 days such patient will be discharge
after10 days of symptom onset and advise for 7 days home
isolation.
• For Severe Cases Clinical recovery and tested negative by RT-
PCR .
8/24/2020 Arati Mishra Ingalageri 25
26. Management of Neonates born to
Mothers with Suspected or
Confirmed COVID-19
• Prevention of transmission
• Contact between mother and neonate
• Breastfeeding
• Management of neonate requiring intensive care
• Visiting neonate admitted to NICU
• Infection control
8/24/2020 Arati Mishra Ingalageri 26
27. Prevention
• Vaccine is best strategy for prevention of any infectious disease.
• For COVID 19 vaccine is under Trial Phase.
• Till that general preventive measures like
Cough etiquette
Social Distancing
8/24/2020 Arati Mishra Ingalageri 27
31. COVID 19 Pediatric v/s Adult
• Recurrent viral infections going on in children up to 5 year of
age so that there immune system is active to fight against new
agent.
• Vaccination will be going on so immune system get stimulated
,All primary vaccination should be given as per schedule
specially prevenar and influenza (First time 2 doses and yearly
once there after).
• Cytokine storm will be less in children as immune system is
developing.
• Cytokine storm play a vital role in severe COVID-19 because
it is associated with ARDS and respiratory failure in patients
with COVID-198/24/2020 Arati Mishra Ingalageri 31
32. Advice for Parents/ Adults who have COVID-19 and
are Staying at Home with a Child
• The affected person should stay in a separate room.
• The affected person should use a 3-ply surgical mask.
• Household members should stay in a different room and be separated from the person as
much as possible.
• Only an assigned family member should be tasked with taking care of the person and should
help with groceries, prescriptions and other personal needs.
• Avoid shaking the soiled linen or direct contact with skin.
• Use disposable gloves when cleaning the surfaces or handling soiled linen.
• Wash hands after removing gloves and before and after eating, drinking & using the
washroom with soap &water (at least 20 s) or with alcohol-based hand sanitizer (at least 30 s).
• Toys that the child plays with should be washed frequently, wherever possible.
• Currently, no prophylaxis is recommended for children.
8/24/2020 Arati Mishra Ingalageri 32
33. Management of Psychological
Issues of Children.
• Provide assurance when ever needed
• Manage child’s Anxiety
• Engage them in indoor activity
• Keep them in contact with their Friends
• Give them clear information
• Make a routine of learning at home
8/24/2020 Arati Mishra Ingalageri 33
34. Implications For Pediatric Nurse
Practitioners For Routine Vaccination
• It is important to continue routine vaccination against vaccine preventable disease,
other wise there will be surge of these cases which may over burden health facility.
• The National Association of Pediatric Nurse Practitioner recommends innovative
solutions to provide safe opportunities to keep vaccination schedules on time including:
1) Separating well and sick visit hours,
2) Staggering appointment times,
3) Closing waiting rooms,
4) Reminding families about upcoming vaccines,
5) Using every patient encounter as an opportunity to administer vaccines
6) Administering as many simultaneous vaccines as possible.
8/24/2020 Arati Mishra Ingalageri 34
35. Strategies for Pediatric OPD and
Emergency Room
• Never allow more then 5 to 10 people at a time.
• Discourage Healthy patient to attend OPD.
• Encourage Telemedicine.
• Separate Waiting Area for patient with flu like symptoms and others.
• Limit number of patient who accompany the patient.
• Face mask and Hand wash or Hand Sanitization is compulsory for all
before entering OPD.
8/24/2020 Arati Mishra Ingalageri 35
36. Continue…
• Encourage cashless transaction.
• Focus on cleaning OPD (Use 1% Hypochlorite solution) every 4 hrs.
• Stethoscope and Thermometer Should be clean between Patient.
• All doctors, nurses in OPD and front desk receptionist must wear face mask.
• Manage OPD According to time slot given by appointment to prevent over
crowding.
• Maintain well ventilated waiting area with social distancing.
8/24/2020 Arati Mishra Ingalageri 36
37. GUIDANCE FOR SCHOOL RE-ENTRY
• The AAP (American Association of Pediatrics)strongly advocates that all policy
consideration for coming school year should start with goal of having students
physically present in school with all precautions.
• Key Principles for School Re entry are,
To open schools safely It is vitally important that community take all necessary
measures to limit the spread of COVID 19.
Schools must take a multi pronged layered approach to protect students teachers
and staff.
School authorities must be in close communication and co ordinate with state
and local health authority.8/24/2020 Arati Mishra Ingalageri 37
38. Continue…
• School re entry should be practical , feasible and appropriate for child
development and address teacher and staff safety.
• Pediatricians, families and schools should partner together to collaborate
identify and develop Accommodation when needed for any child with
unique medical needs.
• School policies should be guided by Supporting over all health and well
being of children, their families and their communities but should also look
to create safe working environment for educators and school staff.
8/24/2020 Arati Mishra Ingalageri 38
39. Key Challenges Faced by Nursing
Professionals During COVID-19
• Providing Support to Reduce Gaps in Critical Knowledge
• Preventing Inadequacies in the Healthcare System
• Policies and Strategies to Prevent Staffing Shortages
• Psychological and Social Support for Patients and Healthcare Professionals
• Research to Enhance Knowledge on COVID-19 Prevention and Management
8/24/2020 Arati Mishra Ingalageri 39